Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Nature Communications|April 26, 2024
CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibitionIrene Andreu-Saumell, Alba Rodriguez-Garcia, Vanessa Mühlgrabner, et al.Cancer Immunology, Immunotherapy : CII|January 10, 2023
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based studyJavier García-Corbacho, Alberto Indacochea, Azucena E González Navarro, et al.Cellular Oncology (Dordrecht, Netherlands)|September 4, 2023
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancerLucía Gutiérrez-Chamorro, Eudald Felip, Eva Castellà, et al.Cancer Immunology, Immunotherapy : CII|February 1, 2025
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal studyJavier García-Corbacho, Alberto Indacochea, Iván Victoria, et al.Journal of the National Cancer Institute|December 28, 2022
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, et al.Ebiomedicine|March 6, 2024
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studiesBenedetta Conte, Fara Brasó-Maristany, Adela Rodríguez Hernández, et al.Pageof 1